Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
01-10-2006 | Palliatieve zorg
Als de patiënt niet meer kan slikken…
Auteurs: Marijse Koelewijn, Bernardina Wanrooij
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Samenvatting
Koelewijn M, Wanrooij BS. Als de patiënt niet meer kan slikken… Huisarts Wet 2006;49(10):519-24.
In dit artikel bespreken we de problemen die kunnen ontstaan als een patiënt in de laatste fase van zijn leven niet meer kan slikken. Achtereenvolgens staan we stil bij vragen over uitdroging, het belang van goede mondverzorging en de mogelijkheden om noodzakelijke medicatie toe te dienen als het langs orale weg niet meer gaat. Van een aantal veelgebruikte medicijnen in deze fase komen vooral de subcutane, transdermale, rectale en transmucosale toedieningswijze aan de orde.
Aan de hand van een casus laten we zien dat het de kwaliteit van leven van de patiënt kan bevorderen als de huisarts al in een eerder stadium in de palliatieve fase de medicatie herziet en alternatieve manieren van toediening overweegt.
Log in om toegang te krijgen
Literatuur
go back to reference Richtlijn dehydratie en vochttoediening. In: De Graeff A, Hesselman GM, Krol RJA, Kuyper MB, Verhagen EH, Vollaard EJ. Palliatieve zorg. Richtlijnen voor de praktijk. Van Wijland: Laren, 2006.
Richtlijn dehydratie en vochttoediening. In: De Graeff A, Hesselman GM, Krol RJA, Kuyper MB, Verhagen EH, Vollaard EJ. Palliatieve zorg. Richtlijnen voor de praktijk. Van Wijland: Laren, 2006.
go back to reference Woodruff R. Palliative Medicine. Evidence-based symptomatic and supportive care for patients with advanced cancer 4th ed. Melbourne: Oxford University Press, 2004.
Woodruff R. Palliative Medicine. Evidence-based symptomatic and supportive care for patients with advanced cancer 4th ed. Melbourne: Oxford University Press, 2004.
go back to reference Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for controle of dehydration in terminal stage-cancer. Int J Palliat Nurse 2000;6:370-4.
Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for controle of dehydration in terminal stage-cancer. Int J Palliat Nurse 2000;6:370-4.
go back to reference Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration and opioid rotation. J Pain Symptom Manage 1995;10:287-91.CrossRefPubMed
Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration and opioid rotation. J Pain Symptom Manage 1995;10:287-91.CrossRefPubMed
go back to reference Morita T, Tey Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 2003;6:557-63.CrossRefPubMed
Morita T, Tey Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 2003;6:557-63.CrossRefPubMed
go back to reference Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 2005;16:640-7.CrossRefPubMed
Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 2005;16:640-7.CrossRefPubMed
go back to reference Boorsma M, Wanrooij BS, Koelewijn M. Sedatie in de palliatieve fase; naar een kalm einde. Huisarts Wet 2005;48:470-4.CrossRef
Boorsma M, Wanrooij BS, Koelewijn M. Sedatie in de palliatieve fase; naar een kalm einde. Huisarts Wet 2005;48:470-4.CrossRef
go back to reference Richtlijn klachten van de mond. In: De Graeff A, Hesselman GM, Krol RJA, Kuyper MB, Verhagen EH, Vollaard EJ. Palliatieve zorg. Richtlijnen voor de praktijk. Van Wijland: Laren, 2006.
Richtlijn klachten van de mond. In: De Graeff A, Hesselman GM, Krol RJA, Kuyper MB, Verhagen EH, Vollaard EJ. Palliatieve zorg. Richtlijnen voor de praktijk. Van Wijland: Laren, 2006.
go back to reference Fürst CJ, Doyle D. The terminal phase. In: Doyle D, Hanks GWC, Cherry NI, Calman KC, editors. Oxford Textbook of Palliative Medicine, 3rd ed. New York: Oxford University Press, 2004.
Fürst CJ, Doyle D. The terminal phase. In: Doyle D, Hanks GWC, Cherry NI, Calman KC, editors. Oxford Textbook of Palliative Medicine, 3rd ed. New York: Oxford University Press, 2004.
go back to reference Wanrooij BS, Koelewijn M, De Graeff A. Het gebruik van corticosteroïden in de palliatieve zorg. Huisarts Wet 2006;49:466-71.
Wanrooij BS, Koelewijn M, De Graeff A. Het gebruik van corticosteroïden in de palliatieve zorg. Huisarts Wet 2006;49:466-71.
go back to reference Wanrooij BS, Koelewijn M. Verlichting van pijn in de palliatieve fase. Huisarts Wet 2005;48:132-9.
Wanrooij BS, Koelewijn M. Verlichting van pijn in de palliatieve fase. Huisarts Wet 2005;48:132-9.
go back to reference Wanrooij BS, Koelewijn M. Verlichting van dyspnoe in de palliatieve fase. Huisarts Wet 2005;48:239-45.
Wanrooij BS, Koelewijn M. Verlichting van dyspnoe in de palliatieve fase. Huisarts Wet 2005;48:239-45.
go back to reference Koelewijn M, Wanrooij BS. De behandeling van misselijkheid en braken in de palliatieve fase. Huisarts Wet 2005;48:179-85.CrossRef
Koelewijn M, Wanrooij BS. De behandeling van misselijkheid en braken in de palliatieve fase. Huisarts Wet 2005;48:179-85.CrossRef
go back to reference Hanks G, Roberts CJC, Davies AN. The principle of drug use in palliative medicine. In: Doyle D, Hanks GWC, Cherry NI, Calman KC, editors. Oxford Textbook of Palliative Medicine, 3rd ed. New York: Oxford University Press, 2004.
Hanks G, Roberts CJC, Davies AN. The principle of drug use in palliative medicine. In: Doyle D, Hanks GWC, Cherry NI, Calman KC, editors. Oxford Textbook of Palliative Medicine, 3rd ed. New York: Oxford University Press, 2004.
go back to reference Spiller JA, Fallon N. The use of Scopoderm in palliative care. Hosp Med 2000;61:782-4.PubMed
Spiller JA, Fallon N. The use of Scopoderm in palliative care. Hosp Med 2000;61:782-4.PubMed
go back to reference Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005;27:655-65.CrossRefPubMed
Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005;27:655-65.CrossRefPubMed
go back to reference Moolenaar F, Fiets G, Visser J, Meijer DK. Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers. Pharm Weekbl Sci 1984;6:237-40.PubMed
Moolenaar F, Fiets G, Visser J, Meijer DK. Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers. Pharm Weekbl Sci 1984;6:237-40.PubMed
go back to reference Warren DE. Practical use of rectal medications in palliative care. J Pain Sympt Manage 1996;11:378-87.CrossRef
Warren DE. Practical use of rectal medications in palliative care. J Pain Sympt Manage 1996;11:378-87.CrossRef
go back to reference Mercadante S, Arcuri E, Fusco F, Tirelli W, Villari P, Bussolino C, et al. Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer 2005;13:702-7.CrossRefPubMed
Mercadante S, Arcuri E, Fusco F, Tirelli W, Villari P, Bussolino C, et al. Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer 2005;13:702-7.CrossRefPubMed
go back to reference Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol 2004;58:156-62.CrossRefPubMed
Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol 2004;58:156-62.CrossRefPubMed
go back to reference Ripamonti C, Zecca E, Brunelli C, Rizzio E, Saita L, Lodi F, et al. Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study. Ann Oncol 1995;6:841-3.PubMed
Ripamonti C, Zecca E, Brunelli C, Rizzio E, Saita L, Lodi F, et al. Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study. Ann Oncol 1995;6:841-3.PubMed
go back to reference Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 1995;62:141-6.CrossRefPubMed
Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 1995;62:141-6.CrossRefPubMed
go back to reference Fine PG, Streisand JB. A review of oral transmucosal fentanyl citrate: potent, rapid and noninvasive opioid analgesia. J Palliat Med 1998;1:55-63.CrossRefPubMed
Fine PG, Streisand JB. A review of oral transmucosal fentanyl citrate: potent, rapid and noninvasive opioid analgesia. J Palliat Med 1998;1:55-63.CrossRefPubMed
go back to reference Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006;(1). DOI:10.1002/14651858.CD004311.pub2.
Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006;(1). DOI:10.1002/14651858.CD004311.pub2.
go back to reference Zeppetella G. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Palliat Med 2001;15:323-8.CrossRefPubMed
Zeppetella G. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Palliat Med 2001;15:323-8.CrossRefPubMed
go back to reference Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005;30:485-91.CrossRefPubMed
Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005;30:485-91.CrossRefPubMed
go back to reference Sinnott C, Lord D. The use of clonazepam for pain in advanced cancer [abstract]. Palliat Med 2000;14:326.
Sinnott C, Lord D. The use of clonazepam for pain in advanced cancer [abstract]. Palliat Med 2000;14:326.
go back to reference Klepstad P, Kaasa S, Cherney N, Hanks G, De Conno F. Research steering committee of the EAPC. Pain and pain treatments in European palliative care unit A cross sectional survey from the European Association of Palliative Care Research Network. Palliat Med 2005;19:477-84.CrossRefPubMed
Klepstad P, Kaasa S, Cherney N, Hanks G, De Conno F. Research steering committee of the EAPC. Pain and pain treatments in European palliative care unit A cross sectional survey from the European Association of Palliative Care Research Network. Palliat Med 2005;19:477-84.CrossRefPubMed
go back to reference Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005;(3). DOI:10.1002/14651858.CD001133.pub2.
Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005;(3). DOI:10.1002/14651858.CD001133.pub2.
go back to reference Schols-Hendriks MW, Lohman JJ, Janknegt R, Korten JJ, Merkus FW, Hooymans PM. Absorption of clonazepam after intranasal and buccal administration. Br J Clin Pharmacol 1995;39:449-51.PubMed
Schols-Hendriks MW, Lohman JJ, Janknegt R, Korten JJ, Merkus FW, Hooymans PM. Absorption of clonazepam after intranasal and buccal administration. Br J Clin Pharmacol 1995;39:449-51.PubMed
go back to reference McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366:182-3.CrossRef
McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005;366:182-3.CrossRef
go back to reference Jeannet PY, Roulet E, Maeder-Ingvar M, Gehri M, Jutzi A, Deonna T. Home and hospital treatment of acute seizures in children with nasal midazolam. Eur J Paediatr Neurol 1999;3:73-7.CrossRefPubMed
Jeannet PY, Roulet E, Maeder-Ingvar M, Gehri M, Jutzi A, Deonna T. Home and hospital treatment of acute seizures in children with nasal midazolam. Eur J Paediatr Neurol 1999;3:73-7.CrossRefPubMed
go back to reference Wilson MT, Macleod S, O’Regan ME. Nasal/buccal midazolam use in the community. Arch Dis Child 2004;89:50-1.CrossRefPubMed
Wilson MT, Macleod S, O’Regan ME. Nasal/buccal midazolam use in the community. Arch Dis Child 2004;89:50-1.CrossRefPubMed
go back to reference Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 2002;17:1318-20.CrossRefPubMed
Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord 2002;17:1318-20.CrossRefPubMed
go back to reference Palliative Care Formulary bulletin-board (communication), 2001. www.palliativedrugs.com.
Palliative Care Formulary bulletin-board (communication), 2001. www.palliativedrugs.com.
Metagegevens
- Titel
- Als de patiënt niet meer kan slikken…
- Auteurs
-
Marijse Koelewijn
Bernardina Wanrooij
- Publicatiedatum
- 01-10-2006
- Uitgeverij
- Bohn Stafleu van Loghum
- DOI
- https://doi.org/10.1007/BF03084906